BioWorld

June 22, 2005

Genaissance, Diagnostics Firm Plan To Merge In $56M Deal

In a bid to fuse diagnostics with pharmacogenomics, Clinical Data Inc. is taking over Genaissance Pharmaceuticals Inc. in an all-stock deal valued at about $56 million. (BioWorld Today) Read More

Inex Cuts More Employees; Cash Will Last Into Next Year

BIO Leaders Point Toward Fresh Lobbying, Public Outreach Efforts

Officer's Death During Protest Mars Convention On Tuesday

Education, Respect Needed To Improve Image of Biotech

Correction

Other News To Note

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for Dec. 17, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 17, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

Drug duo to Repare lack in gyno cancers? Phase I shows promise

BioWorld

Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

Mechanism underlying so-called idiopathic autism inception unveiled

BioWorld Science

Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...